The second day of what at times appeared to provide catharsis for prospective jurors against pharmaceutical executive Martin Shkreli ended on Tuesday without a jury in the securities fraud case.
More than 130 potential jurors were dismissed on Monday, many saying they could not serve because of work commitments and medical reasons. But some were bounced after saying they could not be impartial in a trial for the so-called Pharma bro and seemed to use the proceedings to vent their feelings about the pharmaceutical industry, big business generally or Shkreli specifically.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
